Graf Akcie HTGM (HTG Molecular Diagnostics Inc). Diskuze k akciím HTGM. Aktuální informace HTGM.

Základní informace o společnosti HTG Molecular Diagnostics Inc (Akcie HTGM)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 35.55M
Hodnota podniku (EV) N/A
Tržby 7.869M
EBITDA N/A
Zisk -17.17
Růst v tržbách Q/Q 5.65 %
Růst v tržbách Y/Y -45.33 %
P/E (Cena vůči ziskům) 0.00
Forward P/E -0.34
EV/Sales 3.08
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 4.52
P/FCF N/A
Price/Book 2.45
Účetní hodnota na akcii 2.33
Hotovost na akcii 4.62
FCF vůči ceně -48.34 %
Počet zaměstnanců 84
Tržba na zaměstnance 93.684k
Profit margin -244.13 %
Operating margin -226.93 %
Gross margin 53.31 %
EBIT margin -204.13 %
EBITDA margin -165.97 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -71.11 %
EPS - Očekávaný růst příští rok -33.33 %
Return on assets -47.07 %
Return on equity -104.08 %
ROIC -49.38 %
ROCE -53.23 %
Dluhy/Equity 1.43
Čistý dluh/EBITDA 4.88
Current ratio 5.03
Quick Ratio 4.71
Volatilita 5.38
Beta 0.23
RSI 45.07
Cílová cena analytiků 1
Známka akcie (dle analytiků) N/A
Insider ownership 12.73 %
Institutional ownership 37.10 %
Počet akcií 7.413M
Procento shortovaných akcií 4.06 %
Short ratio 3.21 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie HTGM

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$19.204$21.504$14.76$5.133$4.042$3.329$2.243
Cost Of Goods Sold$8.911$5.091$4.972$4.136$3.336$3.205$2.247
Gross Profit$10.293$16.413$9.788$0.997$0.706$0.124$-0.004
Research And Development Expenses$10.57$12.598$9.997$7.9$4.602$3.075$4.198
SG&A Expenses$18.682$19.975$17.514$17.428$14.994$9.898$7.714
Other Operating Income Or Expenses-------
Operating Expenses$38.164$37.663$32.482$29.464$22.932$16.178$14.159
Operating Income$-18.96$-16.159$-17.723$-24.331$-18.89$-12.849$-11.916
Total Non-Operating Income/Expense$-0.334$-0.291$-1.235$-1.698$-2.498$-1.11$0.146
Pre-Tax Income$-19.294$-16.45$-18.957$-26.029$-21.388$-13.958$-11.769
Income Taxes$-0.003$-0.004$0.003$0.01$0.01--
Income After Taxes$-19.291$-16.447$-18.96$-26.04$-21.398$-13.958$-11.769
Other Income-------
Income From Continuous Operations$-19.291$-16.447$-18.96$-26.04$-21.398$-13.958$-11.769
Income From Discontinued Operations-------
Net Income$-19.298$-16.454$-18.96$-26.04$-22.726$-17.619$-14.191
EBITDA$-17.042$-14.635$-16.022$-22.23$-17.482$-12.011$-11.39
EBIT$-18.96$-16.159$-17.723$-24.331$-18.89$-12.849$-11.916
Basic Shares Outstanding3210000
Shares Outstanding3210000
Basic EPS$-7.65$-9.00$-26.84$-54.87$-75.41$-2624.14$-2211.09
EPS - Earnings Per Share$-7.65$-9.00$-26.84$-54.87$-75.41$-2624.14$-2211.09
# 2020 2019 2018 2017 2016 2015
Current Ratio4.64865.40831.34531.51035.51591.8807
Long-term Debt / Capital0.22280.3145--26.4530.3141-2.4014
Debt/Equity Ratio0.41130.4589-1.8936-2.10610.6391-0.7652
Gross Margin53.59676.327766.314719.421417.473.7262
Operating Margin-98.7306-75.1456-120.0754-474.0409-467.3936-385.9725
EBIT Margin-98.7306-75.1456-120.0754-474.0409-467.3936-385.9725
EBITDA Margin-88.7407-68.0585-108.5517-433.0935-432.5527-360.7896
Pre-Tax Profit Margin-100.4707-76.4996-128.4394-507.1265-529.1898-419.3027
Net Profit Margin-100.4883-76.516-128.4592-507.3236-562.3151-529.2591
Asset Turnover0.42560.49130.69440.27810.10260.3814
Inventory Turnover Ratio7.01873.89594.21152.73711.51521.9011
Receiveable Turnover6.06924.28992.3223.72635.64274.1554
Days Sales In Receivables60.140185.0835157.188797.952964.685187.8385
ROE - Return On Equity-80.4806-77.9765619.7047465.5857-126.663720.0351
Return On Tangible Equity-80.4806-77.9766619.702465.5853-126.6636101.5354
ROA - Return On Assets-42.7554-37.5746-89.1972-141.1036-54.3169-159.9223
ROI - Return On Investment-62.5492-53.4494619.702112781.69-86.8735345.3623
Book Value Per Share6.186311.0625-3.2929-10.561937.0068-618.9395
Operating Cash Flow Per Share0.590716.270123.418116.99241865.3692-82.781
Free Cash Flow Per Share0.672817.196726.077117.331988.2428-88.629

Porovnání s konkurencí: Akcie HTGM

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
HTGM 0.00 N/A -45.33 % -33.33 % -104.08 % 2.45 -244.13 %
Akcie AFMD 0.00 N/A 134.24 % 77.78 % -31.66 % 8.34 -143.35 %
Akcie ADMA 0.00 N/A 56.02 % -21.05 % -76.73 % 1.65 -179.41 %
Akcie CALA 0.00 N/A N/A % -34.38 % -79.58 % 1.46 N/A %
Akcie RDUS N/A N/A 24.04 % 35.71 % 35.68 % -5.77 -45.76 %

Nedávné obchody insiderů: Akcie HTGM

Jméno Obchod Cena Objem
Debra A Gordon
V.P. and Chief Legal Counsel
Prodej
1 Apr 2016
$2.89 $4,832
Tim B Johnson
Executive Chairman
Prodej
1 Apr 2016
$2.89 $14,201
Shaun D Mc Means
SVP, Finance, Admin., and CFO
Prodej
1 Apr 2016
$2.89 $4,627
John L Lubniewski
President and CEO
Prodej
1 Apr 2016
$2.89 $2,300
Plc Glaxosmithkline
10% owner
Prodej
27 Mar 2017
$10.15 $3,045,000
Holdings A/S Novo
10% owner
Prodej
18 Aug 2017
$2.07 $166,813
Holdings A/S Novo
10% owner
Prodej
23 Aug 2017
$1.81 $2,081,162
Shaun D Mc Means
SVP, Finance, Admin., and CFO
Prodej
16 Oct 2017
$2.27 $2,147
Shaun D Mc Means
SVP, Finance, Admin., and CFO
Prodej
1 Nov 2017
$2.26 $2,136
Shaun D Mc Means
SVP, Finance, Admin., and CFO
Prodej
1 Dec 2017
$2.11 $1,994
Tim B Johnson
Executive Chairman
Prodej
26 Dec 2019
$0.72 $4,117

Diskuze k akciím HTGM